Published June 27, 2022 | Version Accepted Version
Journal article Open

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

Description

This is the accepted manuscript version of the work published in its final form as Moodie, Z., Dintwe, O., Sawant, S., Grove, D., Huang, Y., Janes, H., Heptinstall, J., Omar, F. L., Cohen, K., Stephen C De Rosa., Zhang, L., Yates, N. L., Sarzotti-Kelsoe, M., Seaton, K. E., Laher, F., Bekker, L. G., Malahleha, M., Innes, C., Kassim, S., ... McElrath, M. J. (2022). Analysis of the HIV Vaccine Trials Network 702 Phase 2b3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk. The Journal of Infectious Diseases226(2), 246-257. https://doi.org/10.1093/infdis/jiac260

Deposited by shareyourpaper.org and openaccessbutton.org. We've taken reasonable steps to ensure this content doesn't violate copyright. However, if you think it does you can request a takedown by emailing help@openaccessbutton.org.

Files

Files (188.9 kB)

Name Size Download all
md5:932900b219aabd0f87533548cd9a9ba1
188.9 kB Download

Additional details

Related works

Is identical to
10.1093/infdis/jiac260 (DOI)